These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37878295)

  • 1. Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction: A Prespecified Secondary Analysis of the REVIVED-BCIS2 Trial.
    Perera D; Ryan M; Morgan HP; Greenwood JP; Petrie MC; Dodd M; Weerackody R; O'Kane PD; Masci PG; Nazir MS; Papachristidis A; Chahal N; Khattar R; Ezad SM; Kapetanakis S; Dixon LJ; De Silva K; McDiarmid AK; Marber MS; McDonagh T; McCann GP; Clayton TC; Senior R; Chiribiri A;
    JAMA Cardiol; 2023 Dec; 8(12):1154-1161. PubMed ID: 37878295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial.
    Perera D; Morgan HP; Ryan M; Dodd M; Clayton T; O'Kane PD; Greenwood JP; Walsh SJ; Weerackody R; McDiarmid A; Amin-Youssef G; Strange J; Modi B; Lockie T; Hogrefe K; Ahmed FZ; Behan M; Jenkins N; Abdelaal E; Anderson M; Watkins S; Evans R; Rinaldi CA; Petrie MC;
    Circulation; 2023 Sep; 148(11):862-871. PubMed ID: 37555345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction.
    Perera D; Clayton T; O'Kane PD; Greenwood JP; Weerackody R; Ryan M; Morgan HP; Dodd M; Evans R; Canter R; Arnold S; Dixon LJ; Edwards RJ; De Silva K; Spratt JC; Conway D; Cotton J; McEntegart M; Chiribiri A; Saramago P; Gershlick A; Shah AM; Clark AL; Petrie MC;
    N Engl J Med; 2022 Oct; 387(15):1351-1360. PubMed ID: 36027563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction: Cost-Effectiveness Analysis of the REVIVED-BCIS2 Trial.
    Chivardi C; Morgan H; Sculpher MJ; Clayton T; Evans R; Dodd M; Petrie M; Rinaldi CA; O'Kane P; Brown L; Perera D; Saramago P;
    Circ Cardiovasc Qual Outcomes; 2024 Jan; 17(1):e010533. PubMed ID: 37929587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous Revascularization for Ischemic Ventricular Dysfunction: Rationale and Design of the REVIVED-BCIS2 Trial: Percutaneous Coronary Intervention for Ischemic Cardiomyopathy.
    Perera D; Clayton T; Petrie MC; Greenwood JP; O'Kane PD; Evans R; Sculpher M; Mcdonagh T; Gershlick A; de Belder M; Redwood S; Carr-White G; Marber M;
    JACC Heart Fail; 2018 Jun; 6(6):517-526. PubMed ID: 29852933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(16):1-80. PubMed ID: 23074393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of PCI on Health Status in Ischemic Left Ventricular Dysfunction: Insights From REVIVED-BCIS2.
    Ryan M; Taylor D; Dodd M; Spertus JA; Kosiborod MN; Shaukat A; Docherty KF; Clayton T; Perera D; Petrie MC;
    JACC Heart Fail; 2024 Sep; 12(9):1553-1562. PubMed ID: 38727649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Percutaneous Revascularization in Severe Ischemic Left Ventricular Dysfunction.
    Bista R; Zghouzi M; Jasti M; Lichaa H; Kerrigan J; Haddad E; Alraies MC; Paul TK
    Curr Cardiol Rep; 2024 May; 26(5):435-442. PubMed ID: 38642298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization?
    Schinkel AF; Poldermans D; Rizzello V; Vanoverschelde JL; Elhendy A; Boersma E; Roelandt JR; Bax JJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):385-90. PubMed ID: 14762345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypotheses, rationale, design, and methods for prognostic evaluation of a randomized comparison between patients with coronary artery disease associated with ischemic cardiomyopathy who undergo medical or surgical treatment: MASS-VI (HF).
    Rezende PC; Hueb W; Bocchi EA; Farkouh M; Junior CVS; Lima EG; Silva EER; Dallan LAO; Gaiotto FA; Garzillo CL; Rochitte CE; Nomura CH; Scudeler TL; Soares PR; Jatene FB; Ramires JAF; Filho RK
    Trials; 2020 Apr; 21(1):337. PubMed ID: 32299458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of myocardial viability by delayed-enhanced magnetic resonance in patients with coronary artery disease and low ejection fraction: impact of revascularization therapy.
    Gerber BL; Rousseau MF; Ahn SA; le Polain de Waroux JB; Pouleur AC; Phlips T; Vancraeynest D; Pasquet A; Vanoverschelde JL
    J Am Coll Cardiol; 2012 Feb; 59(9):825-35. PubMed ID: 22361403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of patients with chronic coronary artery disease and severe left ventricular dysfunction. The importance of myocardial viability.
    Meluzín J; Cerný J; Spinarová L; Toman J; Groch L; Stetka F; Frélich M; Hude P; Krejcí J; Rambousková L; Panovský R
    Eur J Heart Fail; 2003 Jan; 5(1):85-93. PubMed ID: 12559220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term Outcomes in Patients With Severely Reduced Left Ventricular Ejection Fraction Undergoing Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting.
    Sun LY; Gaudino M; Chen RJ; Bader Eddeen A; Ruel M
    JAMA Cardiol; 2020 Jun; 5(6):631-641. PubMed ID: 32267465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy.
    Panza JA; Ellis AM; Al-Khalidi HR; Holly TA; Berman DS; Oh JK; Pohost GM; Sopko G; Chrzanowski L; Mark DB; Kukulski T; Favaloro LE; Maurer G; Farsky PS; Tan RS; Asch FM; Velazquez EJ; Rouleau JL; Lee KL; Bonow RO
    N Engl J Med; 2019 Aug; 381(8):739-748. PubMed ID: 31433921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction.
    Williams MJ; Odabashian J; Lauer MS; Thomas JD; Marwick TH
    J Am Coll Cardiol; 1996 Jan; 27(1):132-9. PubMed ID: 8522686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STICH3C: Rationale and Study Protocol.
    Fremes SE; Marquis-Gravel G; Gaudino MFL; Jolicoeur EM; Bédard S; Masterson Creber R; Ruel M; Vervoort D; Wijeysundera HC; Farkouh ME; Rouleau JL;
    Circ Cardiovasc Interv; 2023 Aug; 16(8):e012527. PubMed ID: 37582169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. Investigators of this Multicenter Study.
    Meluzín J; Cerný J; Frélich M; Stetka F; Spinarová L; Popelová J; Stípal R
    J Am Coll Cardiol; 1998 Oct; 32(4):912-20. PubMed ID: 9768711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severity of Remodeling, Myocardial Viability, and Survival in Ischemic LV Dysfunction After Surgical Revascularization.
    Bonow RO; Castelvecchio S; Panza JA; Berman DS; Velazquez EJ; Michler RE; She L; Holly TA; Desvigne-Nickens P; Kosevic D; Rajda M; Chrzanowski L; Deja M; Lee KL; White H; Oh JK; Doenst T; Hill JA; Rouleau JL; Menicanti L;
    JACC Cardiovasc Imaging; 2015 Oct; 8(10):1121-1129. PubMed ID: 26363840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.